 |
 |
:: Caris Diagnostics Announces Combination with Molecular Profiling Institute <more...>
:: Molecular Profiling Launches Mammostrat™ - A Novel, Molecular-Targeted, Prognostic Test for Breast Cancer Patients <more...>
:: Molecular Profiling Institute and Specialty Laboratories Launch CardioEvaluatR™ Advanced Testing <more...>
|
|
|  |
|
TBAC facilitates large patient-based clinical trials or R & D studies <more...>
We also offer assay development and testing services to pharmaceutical and biotech companies <more...> |
|
|
|
The Caris MPI was formed by scientific visionaries and drug developers.
With a proven track record in the medical industry, our team is forging strategic alliances with leading medical firms <more...> |
|
|
